organophosphonates has been researched along with Ectromelia, Infectious in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buller, RM; Crump, R; Foster, S; Hartzler, H; Hembrador, E; Lanier, ER; Painter, G; Parker, S; Schriewer, J; Trost, LC | 1 |
| Buller, RM; Crump, R; Korom, M; Parker, S | 1 |
| Buller, RM; Lanier, R; Oberle, C; Painter, G; Parker, S; Robertson, A; Schriewer, J | 1 |
| Buller, RM; Hembrador, E; Lanier, R; Oberle, C; Painter, G; Parker, S; Robertson, A; Siddiqui, AM | 1 |
| Bellone, CJ; Buller, RM; Chen, N; Fredrickson, T; Owens, G; Parker, S; Schriewer, J | 1 |
| Chen, NG; Foster, S; Hartzler, H; Hembrador, E; Hruby, D; Jordan, R; Lanier, R; Mark Buller, R; Painter, G; Painter, W; Parker, S; Sagartz, JE; Schriewer, J | 1 |
| Erez, N; Israely, T; Lustig, S; Melamed, S; Paran, N; Politi, B; Shafferman, A | 1 |
| Beadle, JR; Buller, RM; Hostetler, KY; Melman, L; Owens, G; Schriewer, J | 1 |
| Beaton, S; Fenner, F; Jackson, RJ; Medveczky, J; Ramsay, AJ; Ramshaw, IA; Robbins, SJ | 1 |
| Aldern, KA; Beadle, JR; Buller, RM; Hostetler, KY; Melman, L; Owens, G; Schriewer, J; Trahan, J | 1 |
| Almond, M; Buller, RM; Lampert, B; Oberle, C; Painter, G; Parker, S; Robertson, A; Touchette, E; Trost, LC | 1 |
11 other study(ies) available for organophosphonates and Ectromelia, Infectious
| Article | Year |
|---|---|
Co-administration of the broad-spectrum antiviral, brincidofovir (CMX001), with smallpox vaccine does not compromise vaccine protection in mice challenged with ectromelia virus.
Topics: Animals; Antiviral Agents; Cytosine; Ectromelia virus; Ectromelia, Infectious; Female; Humans; Immunity; Mice; Mice, Inbred C57BL; Organophosphonates; Smallpox Vaccine; Vaccination; Virus Replication | 2014 |
Buccal viral DNA as a trigger for brincidofovir therapy in the mousepox model of smallpox.
Topics: Animals; Antiviral Agents; Cytosine; Disease Models, Animal; DNA, Viral; Ectromelia virus; Ectromelia, Infectious; Mice; Mouth Mucosa; Organophosphonates; Orthopoxvirus; Smallpox | 2017 |
Using biomarkers to stage disease progression in a lethal mousepox model treated with CMX001.
Topics: Alanine Transaminase; Animals; Antiviral Agents; Aspartate Aminotransferases; Biomarkers; Cell Line; Cytosine; Disease Models, Animal; Disease Progression; DNA, Viral; Ectromelia virus; Ectromelia, Infectious; Female; Humans; Interferon-gamma; Mice; Organophosphonates; Treatment Outcome; Weight Loss | 2008 |
Mousepox in the C57BL/6 strain provides an improved model for evaluating anti-poxvirus therapies.
Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Cytokines; Cytosine; Disease Models, Animal; Ectromelia virus; Ectromelia, Infectious; Female; Mice; Mice, Inbred C57BL; Organophosphonates | 2009 |
Poxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: pathogenesis, prophylaxis, and antiviral therapy.
Topics: Animals; Antiviral Agents; Benzamides; Cytosine; Ectromelia virus; Ectromelia, Infectious; Female; Gene Expression Regulation; Interleukin-4; Isoindoles; Mice; Mice, Inbred C57BL; Organophosphonates; Promoter Regions, Genetic; Recombinant Proteins; Survival Analysis; Treatment Outcome | 2011 |
Evaluation of disease and viral biomarkers as triggers for therapeutic intervention in respiratory mousepox - an animal model of smallpox.
Topics: Animals; Benzamides; Biomarkers, Pharmacological; Cell Line; Cytosine; Disease Models, Animal; Drug Evaluation, Preclinical; Ectromelia virus; Ectromelia, Infectious; Female; Humans; Isoindoles; Mice; Mice, Hairless; Mice, Inbred C57BL; Monkeypox virus; Organophosphonates; Smallpox; Variola virus; Virus Replication | 2012 |
A single cidofovir treatment rescues animals at progressive stages of lethal orthopoxvirus disease.
Topics: Animals; Antibodies, Viral; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Ectromelia virus; Ectromelia, Infectious; Female; Immunoglobulin G; Interferon-gamma; Mice; Mice, Inbred BALB C; Organophosphonates; Survival Analysis | 2012 |
Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model.
Topics: Administration, Oral; Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Dose-Response Relationship, Drug; Ectromelia virus; Ectromelia, Infectious; Esters; Female; Inhibitory Concentration 50; Mice; Molecular Structure; Organophosphonates; Organophosphorus Compounds | 2004 |
The efficacy of cidofovir treatment of mice infected with ectromelia (mousepox) virus encoding interleukin-4.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Ectromelia virus; Ectromelia, Infectious; Interleukin-4; Mice; Mice, Inbred C57BL; Organophosphonates | 2005 |
Oral 1-O-octadecyl-2-O-benzyl-sn-glycero-3-cidofovir targets the lung and is effective against a lethal respiratory challenge with ectromelia virus in mice.
Topics: Administration, Oral; Animals; Cidofovir; Cytosine; Ectromelia virus; Ectromelia, Infectious; Female; Liver; Lung; Mice; Organophosphonates; Respiratory Tract Infections | 2007 |
Efficacy of therapeutic intervention with an oral ether-lipid analogue of cidofovir (CMX001) in a lethal mousepox model.
Topics: Administration, Oral; Animals; Antiviral Agents; Cidofovir; Cytosine; Ectromelia virus; Ectromelia, Infectious; Ether; Female; Hepatocytes; Humans; Mice; Mice, Inbred A; Organophosphonates | 2008 |